Georgia Medicaid and tirzepatide
Georgia Medicaid did not cover GLP-1s for weight loss as of January 2026, according to KFF, though it must cover them for type 2 diabetes.
In 2025 Georgia Medicaid paid for 8,964 tirzepatide prescriptions (Mounjaro, Zepbound), 15% of its GLP-1 prescriptions and 35th of the 50 states and DC. It reimbursed $8.8 million before rebates, $984 a prescription against $1,032 nationally.
| Brand | Prescriptions | Medicaid paid | Per Rx |
|---|---|---|---|
| Mounjaro | 8,623 | $8.5 million | $982 |
| Zepbound | 341 | $351,490 | $1,031 |
Georgia plans and prescribing rules
Georgia State Health Benefit Plan (SHBP). Georgia's State Health Benefit Plan covers weight loss medications subject to prior authorization. From October 1, 2026, members no longer have to join the 9amHealth program to get them, and any physician can prescribe.
Tirzepatide in the states around Georgia
| State | Sell tirzepatide, ship there | Cheapest | Medicaid Rx, 2025 | Medicaid, Zepbound for weight loss |
|---|---|---|---|---|
| Georgia | 16 | $69/moWellmedr | 8,964 | Medicaid Zepbound: Not covered (KFF) |
| Alabama | 13 | $69/moWellmedr | 19,804 | Medicaid Zepbound: No |
| Florida | 17 | $69/moWellmedr | 15,477 | Medicaid Zepbound: Not covered (KFF) |
| North Carolina | 17 | $69/moWellmedr | 84,091 | Medicaid Zepbound: Yes |
| South Carolina | 16 | $69/moWellmedr | 9,970 | Medicaid Zepbound: Not confirmed |
| Tennessee | 16 | $69/moWellmedr | 44,570 | Medicaid Zepbound: Yes |



